Edwards Lifesciences ($EW) Insider Trading & Smart Money Activity
Edwards Lifesciences Corporation ($EW) has 4 insider trades, 1 congress trade, 17 13F position changes and 3 analyst ratings on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($99K), net -$99K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 2
- Net insider $ (12 mo)
- -$99K
- Congress trades (12 mo)
- 1
- 13F moves on file
- 17
- Analyst ratings on file
- 3
EW insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 1 / 0 | 0 / 0 |
| Q2 2026 | 0 | 1 · $45.98K | 0 / 0 | 9 / 6 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 1 · $53.02K | 0 / 0 | 0 / 2 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All EW insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13F | Birch Hill Investment Advisors | Reduced | -12.36K sh | $62.41M | — | ||||||
| 13F | Ninety One North America | Reduced | -34.33K sh | $50.25M | — | ||||||
| Insider | Lippis Daniel J.CVP, TAVR | Sell (Open-market sale) 10b5-1 | 619 sh | $53.02K | +4.6% | — | |||||
| Analyst | Barclays | Reiterates to Overweight | PT $110 | +0.8% | — | ||||||
| Insider | Daniel LippisCVP, TAVR | Sell (Option exercise) | 619 sh | +4.8% | -3.9% | Read | |||||
| Insider | Daniel LippisCVP, TAVR | Buy (Option exercise) | 619 sh | $44.99K | +4.8% | -3.9% | Read | ||||
| Analyst | BTIG | Reiterates to buy | PT $110 | +4.8% | -3.9% | Read | |||||
| Insider | Bernard ZovighianCEO | Sell (Open-market sale) 10b5-1 | 523 sh | $45.98K | +3.4% | -1.1% | Read | ||||
| Analyst | RBC Capital | Reiterates to buy | PT $100 | -1.8% | -0.8% | Read | |||||
| 13F | Woodline Partners | Added | +697.54K sh | $159.95M | +5.4% | +6.0% | — | ||||
| 13F | Nomura Asset Management International | Added | +1.66M sh | $237.47M | +5.4% | +6.0% | — | ||||
| 13F | Nomura Asset Management International | Added | +1.66M sh | $250.48M | +5.4% | +6.0% | — | ||||
| 13F | Jacobs Levy Equity Management | Reduced | -182.05K sh | $265.30M | +5.4% | +6.0% | — | ||||
| 13F | Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main | Added | +5.08M sh | $1.10B | +5.4% | +6.0% | — | ||||
| 13F | Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main | Added | +5.08M sh | $1.16B | +5.4% | +6.0% | — | ||||
| 13F | Brown Advisory | Reduced | -302.61K sh | $602.85M | +5.4% | +6.0% | — | ||||
| 13F | Brown Advisory | Reduced | -302.61K sh | $635.89M | +5.4% | +6.0% | — | ||||
| 13F | Artisan Partners Limited Partnership | Added | +4.03M sh | $446.05M | +1.9% | +4.6% | — | ||||
| 13F | Artisan Partners Limited Partnership | Added | +4.03M sh | $470.50M | +1.9% | +4.6% | — | ||||
| 13F | Jennison Associates | Reduced | -714.24K sh | $1.12B | -2.2% | +3.3% | — | ||||
| 13F | Jennison Associates | Reduced | -714.24K sh | $1.19B | -2.2% | +3.3% | — | ||||
| 13F | Ninety One UK | Added | +4.66M sh | $1.06B | -0.2% | +4.0% | — | ||||
| 13F | Ninety One UK | Added | +4.66M sh | $1.12B | -0.2% | +4.0% | — | ||||
| 13F | Assenagon Asset Management S.A. | Reduced | -1.02M sh | $114.90M | +2.5% | +1.9% | Read | ||||
| Congress | Alan Armstrong | Purchase | $1,001 - $15,000 | +2.3% | +5.2% | +8.8% | — |
1W / 1M / 6M = how EW moved from the trade or filing date.
Insider trading in EW: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Lippis Daniel J. | CVP, TAVR | 1 | -$53.02K | Oct 8, 2026 | |
| Daniel Lippis | CVP, TAVR | 2 | — | Jun 30, 2026 | |
| Bernard Zovighian | CEO | 1 | -$45.98K | Jun 17, 2026 |
Members of Congress trading EW
Institutions moving EW (13F)
- Nomura Asset Management International2
- Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main2
- Brown Advisory2
- Artisan Partners Limited Partnership2
- Jennison Associates2
- Ninety One UK2
- Birch Hill Investment Advisors1
- Ninety One North America1
- Woodline Partners1
- Jacobs Levy Equity Management1
- Assenagon Asset Management S.A.1
Analyst ratings on EW
Frequently asked questions
Are EW insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $99K, a net -$99K.
What is the latest insider trade in EW?
Lippis Daniel J., CVP, TAVR filed a sell (open-market sale) of 619 sh worth $53.02K on Oct 8, 2026.
Which members of Congress traded EW?
1 disclosed trade by Alan Armstrong. The latest was on Mar 27, 2026.
Which institutions changed their EW positions?
Recent 13F filers moving the stock include Nomura Asset Management International, Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, Brown Advisory, Artisan Partners Limited Partnership and Jennison Associates.
Other medical devices stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.